News Ticker

[ December 2, 2023 ] Medical Laboratory Scientist – Microbiology – Providence – Santa Monica, CA Los Angeles Biotech Jobs
[ December 1, 2023 ] Sr Cell Therapy Account Manager (West LA / Orange County) – Kite Pharma – Los Angeles, CA Los Angeles Biotech Jobs
[ December 1, 2023 ] Samsung Bioepis strikes deal for Stelara biosimilar, but launch likely won’t come in time for an IRA exemption Los Angeles Biotech News
[ December 1, 2023 ] Senior Associate, Analytical Development – Neogene Therapeutics – Santa Monica, CA Los Angeles Biotech Jobs
[ December 1, 2023 ] Tharimmune’s public offering; Culmination Bio raises $10M; Pepper Bio’s seed round led by NFX Los Angeles Biotech News

Amgen stops trial of Teneobio cancer candidate, taking $650M BiTE out of earnings

October 31, 2023 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off

Amgen stops trial of Teneobio cancer candidate, taking $650M BiTE out of earnings
ntaylor
Tue, 10/31/2023 – 08:49
Click here to view original post

Copyright © 2023 Biotech Networks, LLC